Asami Fujii 1, Yoko Mizutani 1, Yuki Hattori 1, Tomoko Takahashi 1, Hidenori Ohnishi 2, Shozo Yoshida 3, Mariko Seishima 1 , Case Rep Dermatol. 2017 May 22;9(2):13-18.
Sweet’s Syndrome Successfully Treated with Granulocyte and Monocyte Adsorption Apheresis.
After the first session of GMA therapy, all symptoms including the erythematous lesions and fever were completely resolved, and serum G-CSF level was reduced. Leukocyte count, neutrophil count, serum amyloid A protein, and CRP levels were restored within normal ranges by 2 weeks. Thus, GMA therapy can successfully treat a patient with recurrent Sweet’s syndrome, potentially related to the restoration of elevated serum G-CSF levels.
Contact UsFor more informationContact Us